Quentin LASBLEIZ

Quentin Lasbleiz is the Key Account Medical Strategy Lead for Hepatology at GlaxoSmithKline, where they facilitate the connection between hepatology centers of excellence and affiliate medical strategies. Previously, Quentin held positions as a Medical Manager and Medical Sciences Liaison at Roche and InterMune, respectively, and coordinated clinical studies at Eurofins Optimed. They began their career as a General Practitioner at CHU Grenoble Alpes and hold a Master's degree in Managing Innovation in Healthcare, along with a Medical Doctor's degree from Université Grenoble Alpes. Their expertise spans medical affairs, strategic engagement, and patient-centric initiatives in rare diseases and hepatology.